🇺🇸 FDA
Patent

US 7605270

Polymorphic forms of (S).-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) benzylcarbamate

granted A61PA61P1/00A61P17/00

Quick answer

US patent 7605270 (Polymorphic forms of (S).-tetrahydrofuran-3-yl-3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) benzylcarbamate) held by Vertex Pharmaceuticals Incorporated expires Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Oct 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P1/00, A61P17/00, A61P17/06, A61P19/02